A study by a team of researchers across the country, including two from the University of Kentucky, is the first to demonstrate a connection between the characteristics of patients receiving buprenorphine for opioid use disorder and the use of urine drug testing. Lindsey Hammerslag, Ph.D., an assistant research professor in the Division of Biomedical Informatics in the UK College of Medicine, […]
Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available. The study, published today in JAMA Network Open, was supported by the National Institute on Drug Abuse […]
The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic, according to a new study. These data provide evidence that may help to inform buprenorphine prescribing policies. Published today in JAMA Network Open, this study was a collaborative effort […]
A study from researchers at Brown University, Rhode Island Hospital and the University of Rhode Island found that pharmacists — not just physicians at clinics and doctor’s offices — can safely and effectively start patients with opioid use disorder on the lifesaving medication buprenorphine. “With over 100,000 overdose deaths in 2022 and an opioid crisis impacting states across the country, […]
Recent Comments